Andrew Pearlman is Director at MEDGENICS, INC. (MDGN). They have made 2 open-market trades across 1 company since 2012, most recently 2014-02-12.
CIK 0001516544
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MDGN | 51,730 | — |
Shares reported on the most recent Form 4, priced at the 2014-02-14 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDGN | SELL · 10b5-1 | 2014-02-12 | 2014-02-14 | $9.00 | $101K | N/A | N/A | N/A |
| MDGN | SELL · 10b5-1 | 2014-02-04 | 2014-02-06 | $8.00 | $160K | N/A | N/A | N/A |
| MDGN | SELL · 10b5-1 | 2014-01-29 | 2014-01-31 | $7.50 | $188K | N/A | N/A | N/A |
| MDGN | SELL · 10b5-1 | 2014-01-08 | 2014-01-10 | $6.60 | $528K | N/A | N/A | N/A |
| MDGN | SELL | 2012-09-17 | 2012-09-19 | $10.27 | $113K | N/A | N/A | N/A |
| MDGN | SELL | 2012-09-13 | 2012-09-17 | $10.67 | $252K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.